Results 211 to 220 of about 734,103 (389)

Pseudokaposi′s sarcoma

Indian Dermatology Online Journal, 2014
Shylaja Someshwar, Hemangi R Jerajani
openaire   +3 more sources

The Potential of Phytochemicals to Overcome Multidrug Resistance in Metastatic Melanoma

Chemistry &Biodiversity, EarlyView.
ABSTRACT Metastatic melanoma is the most lethal form of skin cancer, accounting for most skin cancer‐related deaths. Immunotherapies and targeted therapies have improved overall and progression‐free survival rates in metastatic melanoma patients. The effectiveness of these therapies decreases due to multidrug resistance (MDR).
Jacqueline Maphutha, Danielle Twilley, Mona Dawood, Thomas Efferth, Namrita Lall   +4 more
wiley   +1 more source

Resection of Esophageal Carcinosarcoma with Residual Sarcoma Post-Chemoradiotherapy: A Case Report. [PDF]

Surg Case Rep
Shibayama R, Takazawa Y, Fujisawa K, Ogawa Y, Shimoyama H, Haruta S, Ueno M.   +6 more
europepmc   +1 more source

The Use of Model-based Iterative Reconstruction to Optimize Chest CT Examinations for Diagnosing Lung Metastases in Patients with Sarcoma

, 2018
Touko Kaasalainen, Teemu Mäkelä, Anna Kelaranta, Mika Kortesniemi   +3 more
openalex   +2 more sources

Toward Anti‐Herpesviral PROTACs: Assessing the Challenges for Targeted Protein Degradation on the Example of Kaposi's Sarcoma‐Associated Herpesvirus Latency‐Associated Nuclear Antigen

ChemMedChem, EarlyView.
It is attempted to employ proteolysis‐targeting chimeras‐based targeted protein degradation to the viral protein “Latency‐associated Nuclear Antigen” from Kaposi's sarcoma‐associated herpesvirus. While ternary complex formation is detected via native mass spectrometry, protein degradation is not observed, presumably due to insufficient permeability ...
Aylin Berwanger, Saskia Catherina Stein, Sarah Brandner, Andreas Martin Kany, Sebastian Heinz, Brigitta Loretz, Claus‐Michael Lehr, Anna Katharina Herta Hirsch, Frederik Lermyte, Thomas Friedrich Schulz, Martin Empting   +10 more
wiley   +1 more source

Efficacy and safety of anlotinib for the treatment of advanced bone and soft tissue sarcomas: a systematic review and meta-analysis. [PDF]

Front Oncol
Li Z, Fang P, Shen S, Zhang L, Xie R, Li C.   +5 more
europepmc   +1 more source

Pazopanib in advanced vascular sarcomas: an EORTC Soft Tissue and Bone Sarcoma Group retrospective analysis [PDF]

, 2016
Attila Kollár, Robin L. Jones, Silvia Stacchiotti, Hans Gelderblom, Michele Guida, Paola Boccone, Neeltje Steeghs, Akmal Safwat, Daniela Katz, F. Duffaud, Stefan Sleijfer, W. van sder Graaf, Nathan Touati, Saskia Litière, Sandrine Marréaud, Alessandro Gronchi, Bernd Kasper   +16 more
openalex   +1 more source

Recurrent retroperitoneal sarcomas: Clinical outcomes of surgical treatment and prognostic factors

, 2021
Del Fiore Paolo, Tropea Saveria
openalex   +2 more sources

An Evaluation of the Drug Interaction Potential of Encorafenib in Combination With Binimetinib Using the Inje Cocktail in Patients With Cancer

Clinical Pharmacology &Therapeutics, EarlyView.
A clinical drug–drug interaction (DDI) study was designed to evaluate the effect of single and multiple oral doses of encorafenib on the single oral dose pharmacokinetics (PK) of the cytochrome P450 (CYP) enzyme probe substrates, losartan (CYP2C9), midazolam (CYP3A4), caffeine (CYP1A2), omeprazole (CYP2C19), and dextromethorphan (CYP2D6) administered ...
Joseph Piscitelli, Micaela B. Reddy, Lance Wollenberg, Laurence Del Frari, Jason Gong, Kyle Matschke, Jason H. Williams   +6 more
wiley   +1 more source

Rare Presentation of Kaposi Sarcoma Mimicking Madura Foot: A Case Report. [PDF]

Clin Case Rep
Nakatudde JN, Kisekka R, Kibudde S.
europepmc   +1 more source